EAH Share Price Performance
UK£0
-0.73 (-100.00%)
Price UK£0
Fair ValueUK£1.53
Share Pricen/a
ECO Animal Health Group plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
EAH Community Narratives
AN
Fair Value
·Fair Value UK£1.53 34.0% undervalued intrinsic discount
Vaccine Delays And Earnings Pressure Will Test Resilience Of Long Term Preventative Push
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value UK£2.02 50.0% undervalued intrinsic discount
Vaccine Approvals And Preventative Health Shift Will Support Stronger Long Term Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value UK£2.57 60.7% undervalued intrinsic discount
Vaccine Pipeline And Animal Protein Demand Will Drive Strong Long Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Vaccine Approvals And Preventative Health Shift Will Support Stronger Long Term Outlook
ECO Animal Health is pushing beyond its main livestock antibiotic into vaccines and other preventative treatments, helped by faster-than-expected approvals and several products nearing launch. The upside comes if this shift sticks and new markets deliver, but the story can wobble if disease outbreaks cool down, approvals slip, or competition bites its flagship product.Read more
AN
UK£2.02
50.0% undervalued intrinsic discount
Fair Value
Revenue
3.46% p.a.
Profit Margin
4.09%
Future PE
43.15x
Price in 2029
UK£2.47
Vaccine Delays And Earnings Pressure Will Test Resilience Of Long Term Preventative Push
ECO Animal Health is trying to shift from relying on a single livestock antibiotic to a bigger, higher-quality mix of preventative products like vaccines, but the first major launch still looks a long way off. If approvals, manufacturing, or partners slip—or farm economics turn against producers in key regions—the business may struggle to turn its research pipeline into steadier growth.Read more
AN
UK£1.53
34.0% undervalued intrinsic discount
Fair Value
Revenue
7.71% p.a.
Profit Margin
4.78%
Future PE
24.75x
Price in 2029
UK£1.87
Vaccine Pipeline And Animal Protein Demand Will Drive Strong Long Term Upside Potential
Catalysts About ECO Animal Health Group ECO Animal Health Group develops and commercializes pharmaceutical and biological products that improve the health and productivity of food producing animals worldwide. What are the underlying business or industry changes driving this perspective?Read more
AN
UK£2.57
60.7% undervalued intrinsic discount
Fair Value
Revenue
5.07% p.a.
Profit Margin
3.37%
Future PE
63.65x
Price in 2028
UK£3.15
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
EAH: Poultry Vaccine Rollout Will Support Higher Sustainable Profitability
Fair Value: UK£2.02 50.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
EAH: Higher Profitability Assumptions Will Support Stronger Future Share Performance
Fair Value: UK£1.53 34.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Vaccine Pipeline And Animal Protein Demand Will Drive Strong Long Term Upside Potential
Fair Value: UK£2.57 60.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
ECO Animal Health Group plc Key Details
About EAH
- Founded
- 1972
- Employees
- 213
- CEO
- WebsiteView website
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
